PharmaPrint

PharmaPrint was a pioneering biotechnology company focused on the standardization and pharmaceuticalization of herbal medicines and dietary supplements. The company utilized a proprietary technology platform to identify, quantify, and stabilize the active chemical constituents of botanical extracts, ensuring batch-to-batch consistency comparable to conventional pharmaceuticals. During its peak, PharmaPrint established high-profile partnerships with major retailers and pharmaceutical companies, including a significant licensing agreement with American Home Products. Despite its innovative approach to bringing clinical rigor to the nutraceutical industry, the company faced severe financial difficulties and regulatory scrutiny, leading to its bankruptcy and the sale of its assets in the early 2000s.